Welcome to our dedicated page for Arcadia Bioscien news (Ticker: RKDA), a resource for investors and traders seeking the latest updates and insights on Arcadia Bioscien stock.
Arcadia Biosciences, Inc. reports developments tied to its plant-based health and wellness products business, including Zola coconut water and agronomic wheat traits. Company news includes operating and financial results, business highlights, material agreements, shareholder voting matters, and capital-structure actions involving its publicly traded common stock.
Recurring updates also cover governance matters, security-structure disclosures, and other corporate events that affect the company's financing, reporting, and operating profile.
Arcadia Biosciences (Nasdaq: RKDA) has announced a national search for a new CEO as Matt Plavan prepares to step down, likely by year-end. Plavan, who joined in 2016 and became CEO in 2019, has led the company through a pivotal transformation from agricultural biotech to consumer packaged goods (CPG). The board emphasizes the need for a leader with CPG experience to build on the current momentum and capitalize on growth opportunities. Arcadia's product portfolio includes health and wellness brands such as GoodWheat and Lief.
Arcadia Biosciences (Nasdaq: RKDA) reported five-fold revenue growth for Q2 2021, reaching $1.4 million compared to $281,000 in Q2 2020. Total revenues for the first half of 2021 were $2.2 million, up from $590,000 a year earlier. The net loss attributable to common stockholders improved 46% to $5.3 million. Key developments include the integration of operations post-Lief acquisition and the sale of Bioceres shares for over $27 million. The appointment of experienced CPG leaders aims to enhance brand awareness and growth.
Arcadia Biosciences (Nasdaq: RKDA) will release its financial and business results for Q2 and the first half of 2021 post-market on August 16, 2021. A conference call is scheduled for 4:30 p.m. Eastern time to discuss these results and strategic achievements. Interested parties can join via U.S. Toll-Free Dial-In at +1-844-243-4690 or International Dial-In at +1-225-283-0138. The call will also be available via live webcast on Arcadia's investor website.
Arcadia Biosciences (Nasdaq: RKDA) has appointed Laura Pitlik as its new chief marketing officer to enhance its consumer goods platforms after key acquisitions. Pitlik, an experienced strategist in consumer packaged goods, will manage brand development and omnichannel marketing for Arcadia's health and wellness portfolio, including brands like GoodWheat and Zola. CEO Matt Plavan highlights this strategic move as a way to position the company for growth in the plant-based food sector, leveraging its innovations in nutrition.
Arcadia Biosciences (Nasdaq: RKDA) reported strong first-quarter financial results for 2021, with revenues increasing by 168% to $828,000, driven by GoodWheat and GLA product sales. The company acquired assets from Lief Holdings and Live Zola, contributing $6 million in annual revenue and expanding its distribution network. However, net income decreased to $2.1 million, down 19% from the previous year, mainly due to non-cash income fluctuations. Operating expenses remained stable at $6.2 million.
On May 17, 2021, Arcadia Biosciences (Nasdaq: RKDA) announced the acquisition of assets from Lief Holdings, LLC and Live Zola, LLC. The deal, valued at $4 million in cash plus 827,400 shares, includes prominent CBD brands such as Soul Spring and Saavy Naturals. This acquisition aims to enhance Arcadia's consumer goods strategy in the CBD market and access distribution channels in over 5,000 stores. With expected annual revenues of $6 million from the acquired brands, Arcadia anticipates revenue growth and operational synergies.
Arcadia Biosciences (Nasdaq: RKDA) will announce its first-quarter financial results on May 17, 2021, after market close. A conference call is scheduled for 4:30 p.m. Eastern time to discuss the results and key strategic achievements for the year. Interested participants can join via U.S. Toll-Free or International Dial-In numbers. The conference call will also be available as a live webcast on the Investors section of Arcadia's website. This session provides an opportunity for investors to gain insights into the company’s performance and future outlook.
Arcadia Biosciences (Nasdaq: RKDA) appointed Belinda Yao as vice president of operations on May 10, 2021. Yao will oversee the supply chain strategy for product manufacturing and production. With over 20 years in management, she brings experience from Zola and The Dannon Company. CEO Matt Plavan stated that Yao's expertise will help build an agile supply chain infrastructure to support the launch of new health and nutrition products. The company focuses on enhancing crop quality and nutritional value through its GoodWheat and GoodHemp brands.
Arcadia Biosciences (Nasdaq: RKDA) has announced that three of its GoodHemp™ seed varieties have received approval from Health Canada, facilitating their sale in Canada. This approval follows certification from the Association of Official Seed Certifying Agencies (AOSCA) and enables Canadian growers to access these high-quality seeds for the 2021 planting season. The approved varieties include Umpqua, Rogue, and Santiam, known for their CBD-dominance and high yield potential. Arcadia has already shipped the first seed order to Tritium 3H, its distribution partner in Canada.
Arcadia Biosciences (Nasdaq: RKDA) announced the acquisition of Agrasys S.A., a Barcelona-based food ingredients company. The deal includes all physical and intellectual property assets of Agrasys, enabling Arcadia to commercialize Tritordeum, a nutritious cereal grain developed by IAS-CSIC. Tritordeum is rich in fiber, protein, and lutein, and is suitable for various foods. Agrasys has already commercialized Tritordeum in 10 countries, including a recent launch with Albert Heijn in Europe. Arcadia aims to expand Tritordeum's market in North America and leverage Agrasys' network for its GoodWheat products.